(Q39840985)

15 September 2017

1 reference

title

Physiological and pharmacological effects of estrogens in breast cancer (English)

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

27 June 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391285

27 June 2022

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391285

27 June 2022

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

27 June 2022

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

27 June 2022

author name string

G. Leclercq

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391285

27 June 2022

J. C. Heuson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391285

27 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=391285

27 June 2022

publication date

1 December 1979

1 reference

15 September 2017

19 December 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=391285

full work available at URL

27 June 2022

https://api.elsevier.com/content/article/PII:0304419X7990012X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

https://api.elsevier.com/content/article/PII:0304419X7990012X?httpAccept=text/plain

27 June 2022

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Biochimica et Biophysica Acta

27 June 2022

published in

1 reference

15 September 2017

volume

560

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

427-455

1 reference

A human cell line from a pleural effusion derived from a breast carcinoma

15 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/51.5.1409

Influence of Synthetic Oestrogens on Advanced Malignant Disease

5

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Journal of Experimental Medicine

19 April 2023

6

25–41

Higgins

1959

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Anti-oestrogens and breast cancer

19 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Effect of anti-oestrogens on initiation of mammary cancer in the female rat.

19 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Growth inhibition of estrogen-dependent rat mammary cancer by EMD 16-795, a new synthetic anti-estrogen

19 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

11

34

1971

De Sombre

1974

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The effect of synthetic anti-oestrogens on the growth and biochemistry of rat mammary tumours

19 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Tamoxifen as an anti-tumour agent: effect on oestrogen binding

19 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

14

37

1537

Tsai

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Antitumour effect of cyclofenil (F6066) on DMBA-induced rat mammary tumors

19 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Clinical trial of nafoxidine, an oestrogen antagonist in advanced breast cancer

19 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases.

19 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study

19 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Clinical trial of nafoxidine in advanced breast cancer

19 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

19 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

19 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Clinical trial of clomiphene in advanced breast cancer

19 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Specific estrogen binding by the cytoplasm fof human breast carcinoma.

19 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The properties of a nuclear acidic protein fraction that binds [6,7-3H]oestradiol-17beta

19 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

28

31

1440

McGuire

1971

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Specific estrogen receptor of the DMBA-induced mammary carcinoma of the rat and its estrogen-requiring molecular transformation

19 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estradiol receptors in mouse mammary tumors: Absence of the transfer of bound estradiol from the cytoplasm to the nucleus

19 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

31

34

2764

Richards

1974

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

32

79

464

Evans

1975

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

36

37

106

Nomura

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogen-binding in vitro by DMBA-induced rat mammary tumors: its relationship to hormone responsiveness

19 April 2023

39

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

40

36

354

De Sombre

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogen Receptors in DMBA-Induced Rat Mammary Tumors before and after Ovariectomy

19 April 2023

41

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

A dissociation between ovarian dependent growth and estrogen sensitivity in mammary carcinoma

19 April 2023

42

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

43

34

3253

Sluyser

1974

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Sex hormone receptors in mammary tumours of GR mice

19 April 2023

44

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Parallelism between oestrogen binding capacity and hormone responsiveness of mammary tumours in GR-A mice

19 April 2023

45

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer

19 April 2023

47

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Receptors and breast cancer: do we know it all?

19 April 2023

48

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

49

46

4595

Lippman

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Human Breast Cancer: Biologically Active Estrogen Receptor in the Absence of Estrogen?

19 April 2023

50

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Mechanism of Action of the Female Sex Hormones

19 April 2023

51

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Mechanism of action of the sex steroid hormones (first of three parts).

19 April 2023

52

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Mechanism of action of the sex steroid hormones (second of three parts).

19 April 2023

53

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Mechanism of action of the sex steroid hormones (third of three parts).

19 April 2023

54

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogen-Induced Uterine Responses and Growth: Relationship to Receptor Estrogen Binding by Uterine Nuclei11

19 April 2023

56

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol

19 April 2023

57

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Temporal Relationships Between Hormone Receptor Binding and Biological Responses inthe Uterus: Studies with Short- and Long-Acting Derivatives of Estriol

19 April 2023

58

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Receptor transformation, the key to estrogen action

19 April 2023

59

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Interaction of activated estradiol-receptor complex and chromatin in isolated uterine nuclei

19 April 2023

60

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Antibody to estrogen-induced protein (IP) and quantification of the protein in rat uterus by a radioimmunoassay

19 April 2023

62

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Co-purification of an oestrogen-induced protein from rat uterus and a factor able to stimulate DNA synthesis in cultured cells

19 April 2023

64

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

X-ray conformation of some estrogens and their binding to uterine receptors

19 April 2023

67

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogenic activity of DDT analogs and polychlorinated biphenyls

19 April 2023

68

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogenicity of o,p'-DDT in rats

19 April 2023

69

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Comparative binding affinity of estrogens and its relation to estrogenic potency

19 April 2023

70

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The influence of synthetic anti-estrogens on the binding of tritiated estradiol-17beta by cytosols of human uterus and human breast carcinoma

19 April 2023

71

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The steroid specificity of the estrogen-receptor of human breast carcinoma

19 April 2023

72

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

Molecular Pharmacology

73

9

520

Raynaud

1973

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogens and Antiestrogens

19 April 2023

74

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The specificity of the estrogen receptor of human uterus

19 April 2023

75

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Photoreactivity of some light-sensitive estrogen derivatives. Use of an exchange assay to determine their photointeraction with the rat uterine estrogen binding protein

19 April 2023

76

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Hexoestrol analogues as probes of oestrogen receptors. I. Importance of hydrogen-bonding groups for receptor binding

19 April 2023

77

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Photoaffinity labels for estrogen binding proteins of rat uterus

19 April 2023

78

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity

19 April 2023

81

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro

19 April 2023

82

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Effects of dichlorodiphenyltrichloroethane (DDT) analogs and polychlorinated biphenyl (PCB) mixtures on 17beta-(3H)estradiol binding to rat uterine receptor

19 April 2023

84

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estradiol dependent decrease of binding inhibition by anti-estrogens (a possible test of receptor activation)

19 April 2023

86

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Binding of [3H]tamoxifen in rat uterine cytosols: a comparison of swinging bucket and vertical tube rotor sucrose density gradient analysis

19 April 2023

87

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor

19 April 2023

89

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

In vitro and in vivo interactions of [3H]dimethylstilbestrol with the estrogen receptor

19 April 2023

90

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted Triphenylethylenes

19 April 2023

91

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

A new derivative of triphenylethylene: effect on implantation and mode of action in rats

19 April 2023

92

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Tamoxifen is a potent "pure" anti-oestrogen in chick oviduct

19 April 2023

93

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogen-binding substances of target tissues

19 April 2023

94

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels

19 April 2023

95

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Nuclear receptor estradiol complex: a requirement for uterotrophic responses.

19 April 2023

96

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Formation of estrogen nuclear receptor in uterus: effect of androgens, estrone and nafoxidine

19 April 2023

97

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The effect of antiestrogens on the nuclear binding of the estrogen receptor.

19 April 2023

98

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogen receptor-anti-estrogen complex: atypical binding by uterine nuclei and effects on uterine growth

19 April 2023

99

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Oestrogen receptors and antagonism of steroid hormone action

19 April 2023

100

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

In vivo effect of anti-estrogens on the localisation and replenishment of estrogen receptor

19 April 2023

101

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Different nuclear binding sites for antiestrogen and estrogen receptor complexes.

19 April 2023

102

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the rat.

19 April 2023

103

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Antiestrogen modulation of the salt-resistant nuclear estrogen receptor

19 April 2023

105

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Antiestrogen Action in the Uterus: Biological Ineffectiveness of Nuclear Bound Estradiol after Antiestrogen123

19 April 2023

106

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogen Receptor Translocation and Replenishment by the Antiestrogen Tamoxifen

19 April 2023

107

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals.

19 April 2023

108

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The metabolism of tamoxifen (I.C.I. 46,474). II. In female patients

19 April 2023

109

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

110

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

[The oestrogenic and anti-oestrogenic properties of ring methyl-substituted stilboestrols]

19 April 2023

111

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Nuclear retention of receptor–oestrogen complex and nuclear acceptor sites

19 April 2023

112

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Dynamics of oestrogen-receptor distribution between the cytosol and nuclear fractions of immature rat uterus after oestradiol administration

19 April 2023

113

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Antiestrogen action: differential nuclear retention and extractability of the estrogen receptor

19 April 2023

114

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

115

37

3344

Watson

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

116

37

951

Welsch

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Growth-stimulating effect of Nafoxidine on rat mammary tumor after ovariectomy

19 April 2023

122

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

124

60

1409

Jordan

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Inhibition of oestrogen-stimulated prolactin release by anti-oestrogens

19 April 2023

125

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Tamoxifen as an anti-tumour agent: oestrogen binding as a predictive test for tumour response

19 April 2023

126

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Effects of oestradiol - 17beta and tamoxifen on total and accessible cytoplasmic oestradiol - 17beta receptors in DMBA-induced rat mammary tumours

19 April 2023

127

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Effects of oestradiol-17β and tamoxifen on nuclear oestradiol-17β receptors in DMBA-induced rat mammary tumours

19 April 2023

128

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Tamoxifen as an anti-tumour agent: role of oestradiol and prolactin

19 April 2023

129

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

133

60

1445

Manni

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

134

60

1437

Morgan

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values.A phase II study

19 April 2023

135

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Preliminary trial of aminoglutethimide in breast cancer

19 April 2023

136

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma

19 April 2023

137

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Aminoglutethimide in treatment of metastatic breast carcinoma

19 April 2023

138

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Oestrogen receptors in breast cancer: a changing concept

19 April 2023

139

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Nuclear oestrogen receptors and treatment of breast cancer

19 April 2023

141

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

144

2903

Boylan

1973

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

145

35

506

Boylan

1975

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

146

38

1814

Vignon

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

148

37

3333

Garola

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

149

38

1948

Panko

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Oestrogen-induced protein in rat mammary tumour and uterus

19 April 2023

151

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogen receptors in the spectrum of breast cancer

19 April 2023

152

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Oestrogen-induced progesterone receptor in human uterus

19 April 2023

153

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment

19 April 2023

162

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

164

37

464

Pichon

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Peroxidase in estrogen-sensitive tissues

19 April 2023

165

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Generality of oestrogen stimulation of peroxidase activity in growth responsive tissues

19 April 2023

166

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

167

35

172

De Sombre

1975

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Regulation of Estrogen Receptors in Ovarian-Dependent Rat Mammary Tumors. I. Effects of Castration and Prolactin

19 April 2023

168

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

On the mechanism of hormone action in 7, 12 dimethylbenz(A) anthracene-induced mammary tumor. I. Prolactin and progesterone effects on estrogen receptor in vitro

19 April 2023

169

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Oestrogen receptor activity and endocrine status in DMBA-induced rat mammary tumours

19 April 2023

170

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

171

36

3736

Gibson

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Effect of prolactin on specific oestradiol erceptors in the rat uterus

19 April 2023

172

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Prolactin and progesterone effect on specific estradiol binding in uterine and mammary tissues in vitro

19 April 2023

173

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Extraovarian effect of prolactin on the traumatized uterus in the rat

19 April 2023

174

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Fluctuations in Levels of Cytosol and Nuclear Estrogen Receptors in Rat Mammary Tumors during the Estrous Cycle*

19 April 2023

175

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

176

30

819

Griswold

1970

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogen receptor levels in hormonally progressive mammary tumors

19 April 2023

177

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Detection and dynamic localisation of estradiol-receptor complexes in intact target cells by immunofluorescence technique

19 April 2023

178

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Cytochemical Study of Estrogen Receptor in Human Mammary Cancer

19 April 2023

179

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Immunofluorescent detection of estrogen receptors in breast cancer.Comparison with dextran-coated charcoal and sucrose gradient assays

19 April 2023

180

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Current status of estrogen and progesterone receptors in breast cancer

19 April 2023

181

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Oestrogen and androgen receptors in breast cancer and response to endocrine therapy

19 April 2023

183

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

184

37

158

Trams

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Affinity of estradiol mustard for estrogen receptors and its enzymatic degradation in uterine and breast cancer cytosols

19 April 2023

186

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

187

62

1255

Leclercq

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Etiology of Human Breast Cancer: A Review2

19 April 2023

189

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The role of hormones in the etiology of human breast cancer

19 April 2023

191

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Urine oestrogen profiles of Asian and North American women

19 April 2023

193

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Estrogen profiles of Oriental and Caucasian women in Hawaii

19 April 2023

194

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

196

37

1901

Lippman

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

197

37

4669

Knight

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

The prognostic significance of estrogen receptors in human breast cancer

19 April 2023

198

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

199

38

3298

Rich

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Relationship between oestrogen-receptor content and histological grade in human primary breast tumours

19 April 2023

200

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication

19 April 2023

202

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

204

35

2039

Heuson

1975

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

207

35

2068

Kim

1975

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study

19 April 2023

209

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90012-X

19 April 2023

Identifiers

1 reference

15 September 2017

1 reference